Clearside Biomedical, Inc. (CLSD) Net Income (Loss) Attributable to Parent USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Clearside Biomedical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2024.
  • Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$11.8 M, a 26.8% decline year-over-year.
  • Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$35 M, a 1.11% decline year-over-year.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.5 M, a 1.4% increase from 2022.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.9 M, a 8863% decline from 2021.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $376 K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$35 M -$11.8 M -$2.48 M -26.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$32.5 M -$4.83 M +$4.83 M +50% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$37.3 M -$9.27 M -$1.44 M -18.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$35.9 M -$9.11 M -$1.29 M -16.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$34.6 M -$9.28 M -$1.64 M -21.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$32.9 M -$9.66 M -$28.4 M -152% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$4.58 M -$7.83 M -$2.94 M -60.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.64 M -$7.81 M -$1.72 M -28.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 $83 K -$7.64 M -$293 K -3.99% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 $376 K $18.7 M +$25.8 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 -$25.4 M -$4.89 M -$2.45 M -101% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$23 M -$6.1 M -$341 K -5.93% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$22.7 M -$7.35 M -$4.44 M -153% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$18.2 M -$7.11 M -$4.02 M -130% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 -$14.2 M -$2.43 M +$4.1 M +62.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.3 M -$5.75 M -$20 K -0.35% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$18.3 M -$2.91 M +$12.5 M +81.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$30.8 M -$3.1 M +$18.5 M +85.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-13
Q3 2019 -$49.3 M -$6.54 M +$17.3 M +72.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$66.6 M -$5.73 M +$15 M +72.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$81.6 M -$15.4 M +$1.2 M +7.24% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$82.8 M -$21.6 M -$5.15 M -31.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$77.7 M -$23.9 M -$5.54 M -30.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-13
Q2 2018 -$72.1 M -$20.7 M -$6.93 M -50.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-13
Q1 2018 -$65.2 M -$16.6 M -$6.23 M -60.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-13
Q4 2017 -$59 M -$16.5 M -$6.81 M -70.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$52.2 M -$18.3 M -$12.7 M -225% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-15
Q2 2017 -$39.5 M -$13.8 M -$8.67 M -170% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-15
Q1 2017 -$30.8 M -$10.4 M -$4.92 M -90.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-15
Q4 2016 -$25.9 M -$9.69 M -$4.52 M -87.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$21.4 M -$5.65 M -$2.17 M -62.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$19.2 M -$5.1 M +$225 K +4.22% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$19.4 M -$5.45 M -$1.69 M -45% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$17.7 M -$5.17 M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$3.48 M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$5.33 M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$3.76 M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.